Ownership history in Bridgefront Capital, LLC · 7 quarters on record
This page tracks every 13F SEC filing in which Bridgefront Capital, LLC reported a position in WEST PHARMACEUTICAL SVSC INC (WST). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 9,348 | +7,925 | +556.9% | 0.65% | $2.6M | $274.89 |
| 2025 Q2 | REDUCED | 1,423 | -1,856 | -56.6% | 0.08% | $311K | $218.25 |
| 2025 Q1 | ADDED | 3,279 | +2,708 | +474.3% | 0.21% | $734K | $223.09 |
| 2023 Q4 | REDUCED | 571 | -61 | -9.7% | 0.15% | $201K | $349.82 |
| 2023 Q3 | REDUCED | 632 | -544 | -46.3% | 0.17% | $237K | $372.54 |
| 2023 Q2 | REDUCED | 1,176 | -389 | -24.9% | 0.24% | $450K | $379.56 |
| 2022 Q3 | INITIATED | 1,565 | — | — | 0.39% | $385K | $243.70 |
As of 2025 Q4 — sorted by position size